Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,928
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
for
PSC
Location: Dallas TX, Indianapolis IN, Rochester MN, Miami FL,
Sponsor: PSC Partners Seeking a Cure
Sex: All
Age: 18 - 70+
Code: NCT06297993
Recruiting
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
for
Solid Tumor, Sarcoma, Leiomyosarcoma,
Location: Irving TX, Houston TX, San Antonio TX, Grand Rapids MI,
Sponsor: STORM Therapeutics LTD
Sex: All
Age: 18+
Code: NCT06975293
Phase1, Phase2, Recruiting
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: Dallas TX, Louisville KY, Duarte CA, Santa Monica CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05685173
Phase1, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Dallas TX, Irving TX, Houston TX, Pueblo CO,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Kingwood TX, Houston TX, Springdale AR,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Dallas TX, Nashville TN, Cleveland OH, Orange CA,
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT05361720
Phase2, Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
for
Cystic Fibrosis Lung
Location: Dallas TX, Kansas City KS, Birmingham AL, Denver CO,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 18+
Code: NCT05248230
Phase2, Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT05958654
Recruiting
Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
for
Throat Carcinoma
Location: Fort Worth TX, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04003051
Phase2, Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
for
Multiple Myeloma
Location: Dallas TX, Atlanta GA, Indianapolis IN, Rochester MN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05137054
Phase1, Recruiting
Telescope Exchange Study
for
Age-related Macular Degeneration
Location: Fort Worth TX, Springfield MO, Memphis TN,
Sponsor: VisionCare, Inc.
Sex: All
Age: 65+
Code: NCT03011554
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Dallas TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
Cancer Clinical Trials Financial Reimbursement Program
for
Cancer Clinical Trials
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 0+
Code: NCT05402033
Recruiting
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
for
Psoriatic Arthritis
Location: Colleyville TX, Omaha NE, El Paso TX, Crossville TN,
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 70+
Code: NCT05669833
Phase3, Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Dallas TX, Oklahoma City OK, Houston TX, Fairway KS,